CEL-SCI Corp (CVM)
1.44
-0.01
(-0.69%)
USD |
NYAM |
Apr 26, 16:00
1.43
-0.01
(-0.69%)
After-Hours: 20:00
CEL-SCI SG&A Expense (Quarterly): 2.133M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.133M |
September 30, 2023 | 2.200M |
June 30, 2023 | 2.454M |
March 31, 2023 | 2.093M |
December 31, 2022 | 2.258M |
September 30, 2022 | 2.487M |
June 30, 2022 | 2.432M |
March 31, 2022 | 3.028M |
December 31, 2021 | 2.760M |
September 30, 2021 | 3.183M |
June 30, 2021 | 3.274M |
March 31, 2021 | 3.312M |
December 31, 2020 | 3.316M |
September 30, 2020 | 3.314M |
June 30, 2020 | 3.192M |
March 31, 2020 | 2.558M |
December 31, 2019 | 2.639M |
September 30, 2019 | 2.331M |
June 30, 2019 | 2.354M |
March 31, 2019 | 1.625M |
December 31, 2018 | 1.689M |
September 30, 2018 | 0.5106M |
June 30, 2018 | 1.749M |
March 31, 2018 | 1.375M |
December 31, 2017 | 2.699M |
Date | Value |
---|---|
September 30, 2017 | 1.452M |
June 30, 2017 | 1.596M |
March 31, 2017 | 1.345M |
December 31, 2016 | 1.407M |
September 30, 2016 | 2.500M |
June 30, 2016 | 1.675M |
March 31, 2016 | 1.678M |
December 31, 2015 | 0.6346M |
September 30, 2015 | 2.878M |
June 30, 2015 | 2.863M |
March 31, 2015 | 2.880M |
December 31, 2014 | 5.221M |
September 30, 2014 | 4.208M |
June 30, 2014 | 2.398M |
March 31, 2014 | 2.088M |
December 31, 2013 | 1.971M |
September 30, 2013 | 1.554M |
June 30, 2013 | 1.778M |
March 31, 2013 | 1.649M |
December 31, 2012 | 2.001M |
September 30, 2012 | 1.441M |
June 30, 2012 | 1.669M |
March 31, 2012 | 1.631M |
December 31, 2011 | 1.854M |
September 30, 2011 | 1.288M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.093M
Minimum
Mar 2023
3.316M
Maximum
Dec 2020
2.701M
Average
2.558M
Median
Mar 2020
SG&A Expense (Quarterly) Benchmarks
Boston Scientific Corp | 1.364B |
The Cigna Group | 4.062B |
Synlogic Inc | 3.27M |
BioXcel Therapeutics Inc | 9.603M |
IGM Biosciences Inc | 11.58M |